Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Sunrise Pharmaceutical, Inc.
FDA Inspection
•Sunrise Pharmaceutical, Inc.•July 17, 2009

Sunrise Pharmaceutical, Inc. – FDA Inspection, Jul 17, 2009

Record Details

This FDA Inspection record concerns Sunrise Pharmaceutical, Inc., with an inspection on July 17, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Sunrise Pharmaceutical, Inc.
Inspection Date
July 17, 2009
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 2b4ff6da-2de9-4c21-8104-d791c0c3705a

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
599659
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

11
  1. 21 CFR 211.68(b)Computer control of master formula records
  2. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  3. 21 CFR 211.160(a)Deviations from laboratory control requirements
  4. 21 CFR 211.165(f)Failing drug products not rejected
  5. 21 CFR 211.125(b)Examination of issued labels
  6. 21 CFR 211.115(a)Reprocessing procedures not written or followed
  7. 21 CFR 211.165(e)Test methods
  8. 21 CFR 211.160(a)Lab controls established, including changes
  9. 21 CFR 211.192Investigations of discrepancies, failures
  10. 21 CFR 211.22(d)Procedures not in writing, fully followed

Showing 10 of 11 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Sunrise Pharmaceutical, Inc.

8
DateClassificationOfficeProject area
March 31, 2026Not classifiedNew Jersey District OfficeDrug Quality Assurance
January 27, 2023NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 18, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 22, 2017Not classifiedNew Jersey District Office
April 6, 2017NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for Sunrise Pharmaceutical, Inc.
  • FDA Inspection 1310416 - 2026-03-31
  • FDA Inspection 1198356 - 2023-01-27
  • FDA Inspection 1038016 - 2018-01-18
  • FDA Inspection 1016794 - 2017-06-22
  • FDA Inspection 1013086 - 2017-04-06

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sunrise Pharmaceutical, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.